We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $133B
1-Year Est. Return 43.5%
This Fund
S&P 500
This Quarter Est. Return
+14.19%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$117B
AUM Growth
+$9.87B
Cap. Flow
-$1.11B
Cap. Flow %
-0.95%
Top 10 Hldgs %
30.52%
Holding
4,391
New
216
Increased
2,182
Reduced
1,537
Closed
202

Top Buys

Rank Stock Value
1
COF icon
Capital One
COF
+$89.2M
2
FLUT icon
Flutter Entertainment
FLUT
+$43.9M
3
OKTA icon
Okta
OKTA
+$32.1M
4
CHWY icon
Chewy
CHWY
+$31.8M
5
COIN icon
Coinbase
COIN
+$26.9M

Sector Composition

Rank Sector Weight
1 Technology 31.83%
2 Financials 13.86%
3 Consumer Discretionary 10.91%
4 Healthcare 9.41%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAND
3651
DELISTED
Sandstorm Gold
SAND
$18 ﹤0.01%
2
POET icon
3652
POET Technologies
POET
$1.53B
$15 ﹤0.01%
3
-45
-94% -$190
BPTS
3653
DELISTED
Biophytis SA American Depositary Share (0.01 Euro)
BPTS
$12 ﹤0.01%
9
-10
-53% -$13
SST icon
3654
System1
SST
$19.8M
-3,397
Closed -$15.1K
NXE icon
3655
NexGen Energy
NXE
$7.12B
$6 ﹤0.01%
1
SOS
3656
SOS Limited
SOS
$16.3M
$6 ﹤0.01%
1
KWK
3657
DELISTED
QUICKSILVER RESOURCES INC
KWK
$6 ﹤0.01%
1,604
SPRC icon
3658
SciSparc
SPRC
$3.64M
0
ADVNB
3659
DELISTED
Advanta Corp Class B
ADVNB
$3 ﹤0.01%
1,650
ABCL icon
3660
AbCellera Biologics
ABCL
$3.11B
-135
Closed -$301
ABOS icon
3661
Acumen Pharmaceuticals
ABOS
$179M
-45,516
Closed -$50.1K
ACHV icon
3662
Achieve Life Sciences
ACHV
$689M
-42,267
Closed -$113K
ACRV icon
3663
Acrivon Therapeutics
ACRV
$73.2M
-16,600
Closed -$33.7K
ACWI icon
3664
iShares MSCI ACWI ETF
ACWI
$33.4B
-11,224
Closed -$1.31M
ADVM
3665
DELISTED
Adverum Biotechnologies
ADVM
-32,999
Closed -$144K
AKA icon
3666
a.k.a. Brands
AKA
$116M
-1,155
Closed -$15.6K
ALXO icon
3667
ALX Oncology
ALXO
$277M
-46,302
Closed -$28.8K
AMTX icon
3668
Aemetis
AMTX
$123M
-51,641
Closed -$89.8K
ARCO icon
3669
Arcos Dorados Holdings
ARCO
$1.66B
-1,056
Closed -$8.51K
ATNM icon
3670
Actinium Pharmaceuticals
ATNM
$25.4M
-42,284
Closed -$68.1K
ATOS icon
3671
Atossa Therapeutics
ATOS
$23.5M
-8,657
Closed -$87.4K
BAER icon
3672
Bridger Aerospace
BAER
$71.2M
-15,246
Closed -$17.2K
BDTX icon
3673
Black Diamond Therapeutics
BDTX
$118M
-54,836
Closed -$85K
CMRC
3674
Commerce.com Inc Series 1
CMRC
$181M
-101,451
Closed -$584K
BLCO icon
3675
Bausch + Lomb
BLCO
$6.01B
-107
Closed -$1.55K

Similar funds

RhumbLine Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, RhumbLine Advisers held 4,391 positions worth $117B, up 9.2% from $107B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

RhumbLine Advisers's Q2 2025 filing shows 216 new, 2,182 increased, 1,537 reduced and 202 closed positions. Its largest new stake was Ralliant Corp: 320,982 shares worth $15.6M. The largest sale was Discover Financial Services, an estimated $91M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q2 2025 buy was Ralliant Corp: 320,982 shares worth $15.6M.
  • RhumbLine Advisers added most to Capital One in Q2 2025, an estimated $89.2M increase.
  • RhumbLine Advisers's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $75.5M.
  • RhumbLine Advisers fully exited Discover Financial Services in Q2 2025, selling an estimated $91M.
  • RhumbLine Advisers's ten largest holdings make up 31% of its $117B portfolio in Q2 2025.
  • RhumbLine Advisers opened 216 new positions and closed 202 in Q2 2025.
  • RhumbLine Advisers's portfolio value rose 9.2% quarter-over-quarter to $117B.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.